134 related articles for article (PubMed ID: 9202817)
1. Hepatitis B vaccine booster dose: low-dose recombinant hepatitis B vaccines as a booster dose.
Bryan JP; MacArthy P; Rudock A; Fogarty JP; Dowd H; Legters LJ; Perine PL
Am J Infect Control; 1997 Jun; 25(3):215-22. PubMed ID: 9202817
[TBL] [Abstract][Full Text] [Related]
2. Comparative long term immunogenicity of two recombinant hepatitis B vaccines and the effect of a booster dose given after five years in a low endemicity country.
Duval B; Gîlca V; Boulianne N; De Wals P; Massé R; Trudeau G; De Serres G
Pediatr Infect Dis J; 2005 Mar; 24(3):213-8. PubMed ID: 15750456
[TBL] [Abstract][Full Text] [Related]
3. Differences in response to a hepatitis B vaccine booster dose among Alaskan children and adolescents vaccinated during infancy.
Samandari T; Fiore AE; Negus S; Williams JL; Kuhnert W; McMahon BJ; Bell BP
Pediatrics; 2007 Aug; 120(2):e373-81. PubMed ID: 17636112
[TBL] [Abstract][Full Text] [Related]
4. Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a 15-year follow-up study.
Bialek SR; Bower WA; Novak R; Helgenberger L; Auerbach SB; Williams IT; Bell BP
Pediatr Infect Dis J; 2008 Oct; 27(10):881-5. PubMed ID: 18756185
[TBL] [Abstract][Full Text] [Related]
5. Randomized comparison of 5 and 10 microgram doses of two recombinant hepatitis B vaccines.
Bryan JP; Craig PG; Reyes L; Hakre S; Jaramillo R; Harlan H; MacArthy P; Legters LJ
Vaccine; 1995 Aug; 13(11):978-82. PubMed ID: 8525691
[TBL] [Abstract][Full Text] [Related]
6. Booster immunization of low- and non-responders after a standard three dose hepatitis B vaccine schedule--results of a post-marketing surveillance.
Clemens R; Sänger R; Kruppenbacher J; Höbel W; Stanbury W; Bock HL; Jilg W
Vaccine; 1997 Mar; 15(4):349-52. PubMed ID: 9141203
[TBL] [Abstract][Full Text] [Related]
7. Comparison of a triple antigen and a single antigen recombinant vaccine for adult hepatitis B vaccination.
Young MD; Gooch WM; Zuckerman AJ; Du W; Dickson B; Maddrey WC
J Med Virol; 2001 Jul; 64(3):290-8. PubMed ID: 11424117
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the response to a booster dose of hepatitis B vaccine in previously immunized healthcare workers.
Williams JL; Christensen CJ; McMahon BJ; Bulkow LR; Cagle HH; Mayers JS; Zanis CL; Parkinson AJ; Margolis HS
Vaccine; 2001 Jul; 19(28-29):4081-5. PubMed ID: 11427285
[TBL] [Abstract][Full Text] [Related]
9. Comparative safety and immunogenicity of two recombinant hepatitis B vaccines given to infants at two, four and six months of age.
Greenberg DP; Vadheim CM; Wong VK; Marcy SM; Partridge S; Greene T; Chiu CY; Margolis HS; Ward JI
Pediatr Infect Dis J; 1996 Jul; 15(7):590-6. PubMed ID: 8823852
[TBL] [Abstract][Full Text] [Related]
10. Randomized, comparative trial of 20 micrograms vs 40 micrograms Engerix B vaccine in hepatitis B vaccine non-responders.
Goldwater PN
Vaccine; 1997 Mar; 15(4):353-6. PubMed ID: 9141204
[TBL] [Abstract][Full Text] [Related]
11. A randomized trial of alternative two- and three-dose hepatitis B vaccination regimens in adolescents: antibody responses, safety, and immunologic memory.
Cassidy WM; Watson B; Ioli VA; Williams K; Bird S; West DJ
Pediatrics; 2001 Apr; 107(4):626-31. PubMed ID: 11335734
[TBL] [Abstract][Full Text] [Related]
12. Intradermal vaccination of adults with three low doses (2 micrograms) of recombinant hepatitis B vaccine. II. Persistence of immunity and induction of immunologic memory.
Elisbão Mdo C; Baldy JL; Bonametti AM; Reiche EM; Morimoto HK; Pontello R; Matsuo T; Ferelle A; Neves J
Mem Inst Oswaldo Cruz; 2003 Dec; 98(8):1109-13. PubMed ID: 15049099
[TBL] [Abstract][Full Text] [Related]
13. Long-term persistence in protection and response to a hepatitis B vaccine booster among adolescents immunized in infancy in the western region of China.
Wang ZZ; Gao YH; Lu W; Jin CD; Zeng Y; Yan L; Ding F; Li T; Liu XE; Zhuang H
Hum Vaccin Immunother; 2017 Apr; 13(4):909-915. PubMed ID: 27874311
[TBL] [Abstract][Full Text] [Related]
14. Antibody and immune memory persistence after vaccination of preadolescents with low doses of recombinant hepatitis B vaccine.
Gilca V; De Serres G; Boulianne N; De Wals P; Murphy D; Trudeau G; Deceuninck G; Massé R; Duval B
Hum Vaccin; 2010 Feb; 6(2):212-8. PubMed ID: 19946212
[TBL] [Abstract][Full Text] [Related]
15. Safety and immunogenicity of a modified process hepatitis B vaccine in healthy adults ≥50 years.
Gilbert CL; Klopfer SO; Martin JC; Schödel FP; Bhuyan PK
Hum Vaccin; 2011 Dec; 7(12):1336-42. PubMed ID: 22185811
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B immune memory in children primed with hexavalent vaccines and given monovalent booster vaccines: an open-label, randomised, controlled, multicentre study.
Zanetti AR; Romanò L; Giambi C; Pavan A; Carnelli V; Baitelli G; Malchiodi G; Valerio E; Barale A; Marchisio MA; Montù D; Tozzi AE; D'Ancona F;
Lancet Infect Dis; 2010 Nov; 10(11):755-61. PubMed ID: 20884297
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity of two recombinant hepatitis B vaccines in older individuals.
Treadwell TL; Keeffe EB; Lake J; Read A; Friedman LS; Goldman IS; Howell CD; DeMedina M; Schiff ER; Jensen DM
Am J Med; 1993 Dec; 95(6):584-8. PubMed ID: 8259774
[TBL] [Abstract][Full Text] [Related]
18. Response to a booster dose 18 months after a low anti-HBs response (10-99 IU/l) to three doses of intradermally or intramuscularly administered recombinant hepatitis B vaccine.
Struve J; Aronsson B; Frenning B; Forsgren M; Weiland O
Infection; 1995; 23(1):42-5. PubMed ID: 7744490
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of initiating a hepatitis B vaccination schedule with one vaccine and completing it with another.
Bush LM; Moonsammy GI; Boscia JA
Vaccine; 1991 Nov; 9(11):807-9. PubMed ID: 1836921
[TBL] [Abstract][Full Text] [Related]
20. Immune persistence 17 to 20 years after primary vaccination with recombination hepatitis B vaccine (CHO) and the effect of booster dose vaccination.
Zhao YL; Han BH; Zhang XJ; Pan LL; Zhou HS; Gao Z; Hao ZY; Wu ZW; Ma TL; Wang F; Li Q; Bi SL; Ma JC
BMC Infect Dis; 2019 May; 19(1):482. PubMed ID: 31146699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
